Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial

Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision metadata updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:16:35.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added related topics: Multiple Myeloma and MedlinePlus Genetics to the page to improve access to contextual information.
    Difference
    0.2%
    Check dated 2026-03-04T10:28:40.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    - Deleted the related topics entry for 'Multiple myeloma' and MedlinePlus Genetics; core trial details and page structure remain unchanged.
    Difference
    0.2%
    Check dated 2026-02-18T03:51:33.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a related topic for Multiple myeloma and MedlinePlus Genetics; updated page revision to v3.4.2. Removed the government funding lapse notice and prior revision v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-11T02:43:40.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a site revision tag (Revision: v3.4.1). Removed the 'Multiple Myeloma' topic and related MedlinePlus Genetics entry, along with the prior revision tag (v3.4.0); To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-04T01:52:07.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Minor UI and metadata updates were made on the study page, including a glossary toggle, addition of related topics (Multiple myeloma and MedlinePlus Genetics), and a footer revision from v3.3.4 to v3.4.0 with capitalization tweaks to 'Last Update Submitted that Met QC Criteria' and related entries. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-28T00:30:57.000Z thumbnail image

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.